Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on April 8, 2009
J Am Soc Nephrol 20: 1069-1077, 2009
© 2009 American Society of Nephrology
doi: 10.1681/ASN.2008070730

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Press Release
Right arrow All Versions of this Article:
ASN.2008070730v1
20/5/1069    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hallan, S. I.
Right arrow Articles by Orth, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hallan, S. I.
Right arrow Articles by Orth, S. R.
Related Collections
Right arrowRelated Articles

CLINICAL EPIDEMIOLOGY

Combining GFR and Albuminuria to Classify CKD Improves Prediction of ESRD

Stein I. Hallan*,{dagger}, Eberhard Ritz{ddagger}, Stian Lydersen*, Solfrid Romundstad*,{dagger}, Kurt Kvenild§ and Stephan R. Orth||

Departments of * Cancer Research and Molecular Medicine and § Community Medicine and General Practice, Faculty of Medicine, Norwegian University of Science and Technology, and {dagger} Department of Medicine, Division of Nephrology, St. Olav University Hospital, Trondheim, Norway; and {ddagger} Department of Medicine, Division of Nephrology, Ruperto Carola University Heidelberg, Heidelberg, and || Dialysis Center Bad Aibling, Bad Aibling, and Department of Internal Medicine II, University of Regensburg, Regensburg, Germany

Correspondence: Dr. Stein I. Hallan, Department of Medicine, St. Olav University Hospital, N-7006 Trondheim, Norway. Phone: 0047-7386-7273; Fax: 0047-7386-9390; E-mail: stein.hallan{at}ntnu.no

Received for publication July 15, 2008. Accepted for publication November 24, 2008.

Despite the high prevalence of chronic kidney disease (CKD), relatively few individuals with CKD progress to ESRD. A better understanding of the risk factors for progression could improve the classification system of CKD and strategies for screening. We analyzed data from 65,589 adults who participated in the Nord-Trøndelag Health (HUNT 2) Study (1995 to 1997) and found 124 patients who progressed to ESRD after 10.3 yr of follow-up. In multivariable survival analysis, estimated GFR (eGFR) and albuminuria were independently and strongly associated with progression to ESRD: Hazard ratios for eGFR 45 to 59, 30 to 44, and 15 to 29 ml/min per 1.73 m2 were 6.7, 18.8, and 65.7, respectively (P < 0.001 for all), and for micro- and macroalbuminuria were 13.0 and 47.2 (P < 0.001 for both). Hypertension, diabetes, male gender, smoking, depression, obesity, cardiovascular disease, dyslipidemia, physical activity and education did not add predictive information. Time-dependent receiver operating characteristic analyses showed that considering both the urinary albumin/creatinine ratio and eGFR substantially improved diagnostic accuracy. Referral based on current stages 3 to 4 CKD (eGFR 15 to 59 ml/min per 1.73 m2) would include 4.7% of the general population and identify 69.4% of all individuals progressing to ESRD. Referral based on our classification system would include 1.4% of the general population without losing predictive power (i.e., it would detect 65.6% of all individuals progressing to ESRD). In conclusion, all levels of reduced eGFR should be complemented by quantification of urinary albumin to predict optimally progression to ESRD.


Related Articles

CKD Classification: Time to Move Beyond KDOQI
T. Alp Ikizler
J. Am. Soc. Nephrol. 2009 20: 929-930. [Full Text] [PDF]

This Month's Highlights
J. Am. Soc. Nephrol. 2009 20: A14. [Full Text] [PDF]

CKD Classification: Time to Move Beyond KDOQI
T. Alp Ikizler
J. Am. Soc. Nephrol. 2009 20: 929-930. [Full Text] [PDF]



This article has been cited by other articles:


Home page
CJASNHome page
G. Jain, R. C. Campbell, and D. G. Warnock
Mineralocorticoid Receptor Blockers and Chronic Kidney Disease
Clin. J. Am. Soc. Nephrol., October 1, 2009; 4(10): 1685 - 1691.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
S. S. Waikar and W. C. Winkelmayer
Chronic on Acute Renal Failure: Long-term Implications of Severe Acute Kidney Injury
JAMA, September 16, 2009; 302(11): 1227 - 1229.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. Munkhaugen, S. Lydersen, P. R. Romundstad, T.-E. Wideroe, B. E. Vikse, and S. Hallan
Kidney function and future risk for adverse pregnancy outcomes: a population-based study from HUNT II, Norway
Nephrol. Dial. Transplant., July 3, 2009; (2009) gfp320v1.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
T. A. Ikizler
CKD Classification: Time to Move Beyond KDOQI
J. Am. Soc. Nephrol., May 1, 2009; 20(5): 929 - 930.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP